Scarica l'app Stockscreener
27.00
1.24%
0.33
Dopo l'orario di chiusura:
27.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Pfizer Tests Transparent Eliquis Pricing As Valuation Signals Undervaluation - Yahoo Finance
There Are Early Signals Ahead of Tafamidis Trial As Analysts See Potential Upside for Pfizer (PFE) and BridgeBio Pharma (BIO) - Markets Herald
Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom? - The Motley Fool
Pfizer (PFE) Quietly Reloads Pipeline With Bold New Bets - TipRanks
Is Pfizer's 6% Dividend Yield Safe? Here's What Investors Need to Know. - Yahoo Finance
Pfizer Eliquis Price Move With Cost Plus Raises Questions On Valuation - simplywall.st
Generali Investments Management Co LLC Purchases 65,552 Shares of Pfizer Inc. $PFE - MarketBeat
Calamos Advisors LLC Has $47.79 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Pfizer (NYSE:PFE) Shares Up 1.3%What's Next? - MarketBeat
Expanding Direct-To-Patient Options, BMS/Pfizer Add Eliquis To Cost Plus Drugs Portal - Citeline News & Insights
Pfizer, Dexcel Drop Heart Drug Case Before Bench Trial - Law360
Is Pfizer’s Healthcare Reset Gaining Ground Through Obesity Care? - Kalkine Media
BridgeBio gains amid report of settlement in Pfizer Vyndamax patent dispute - Seeking Alpha
Bristol Myers Squibb-Pfizer Alliance to sell Eliquis on Mark Cuban’s Cost Plus Drugs - ROI-NJ
Bristol Myers, Pfizer Bring Eliquis to Cost Plus at $345 Monthly - GuruFocus
Bristol Myers Squibb (BMY) and Pfizer (PFE) Launch Eliquis on Co - GuruFocus
Pfizer Plans To Challenge $9.1M Tax Bill In India - Law360
Wall Street Says Buy Merck Over Pfizer. The Numbers Tell a More Complicated Story. - Barchart.com
Pfizer Inc. (PFE): One of the Best Safe Stocks to Invest in for Beginners - Insider Monkey
Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy - Reuters
Pfizer presents auristatin S ADC for GPNMB tumors - BioWorld News
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company - marketscreener.com
Pfizer Obesity Pipeline Expands As Monthly GLP 1 Candidate Targets Growth - simplywall.st
Pfizer Ltd Receives Tax Demand Of 857.4 Million Rupees - TradingView
Ahead of NFL Draft night, Fernando Mendoza signs with Pfizer - Medical Marketing and Media
Pfizer stock drops 1.57% as AI accelerates cancer research participation and discovery - Traders Union
Pfizer : Announces 2026 Shareholder Meeting Preliminary ResultsCorporateFinance - marketscreener.com
Pfizer Advances PF-08653944 Liver Study, Reinforcing Long-Term Pipeline Visibility - TipRanks
Pfizer Advances Early-Stage Obesity Asset With New Gastric Emptying Study - TipRanks
Albert Bourla: Pharmaceutical Visionary, COVID-19 Vaccine Champion, and Chairman and CEO of Pfizer - BBN Times
Torray Investment Partners LLC Boosts Stake in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Shares Sold by Mystic Asset Management Inc. - MarketBeat
Pfizer Inc. to Issue Quarterly Dividend of $0.43 (NYSE:PFE) - MarketBeat
The Escalator: Pfizer, Eton Pharmaceuticals, Steak ‘n Shake and more - Medical Marketing and Media
PFE (Pfizer Inc.) posts 14.3 percent Q4 2025 EPS beat, stock rises 1.25 percent in regular trading.Community Exit Signals - UBND thành phố Hải Phòng
Pfizer’s Monthly GLP-1 Push Tests Balance Between Obesity Growth And Dividends - Yahoo Finance
Pfizer Inc. (NYSE:PFE) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Pfizer declares $0.43 dividend - MSN
Pfizer declares $0.43 quarterly dividend payable in June By Investing.com - Investing.com India
Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Pfizer Keeps Quarterly Dividend at $0.43 a Share, Payable June 12 to Shareholders of Record May 8 - marketscreener.com
Pfizer Declares Second-Quarter 2026 Dividend - Business Wire
Pfizer to cut around 100 jobs at Ringaskiddy plant - RTE.ie
New C. diff vaccine efforts coincide with Pfizer stock dip amid rangebound technicals - Traders Union
Should You Forget Pfizer and Buy This Pharma Stock Instead? - The Globe and Mail
Pfizer CFO Dave Denton on Oncology, Obesity, and Pfizer’s Next Growth Cycle - Yahoo Finance
Pfizer Inc. $PFE Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Pfizer Could Surprise Again This Earnings Season (Preview) (NYSE:PFE) - Seeking Alpha
Pfizer GLP-1 weight loss drug available for pre-order in China - Reuters
Pfizer Lyme Disease Vaccine Shows Over 70 Percent Efficacy - HarianBasis.co
Pfizer Oncology Pivot In Focus As ASCO 2026 Data And PADCEV Loom - simplywall.st
Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 - BioSpace
ZAWYA: Egypt, Pfizer explore local vaccine production, pharma innovation partnerships - TradingView
Pfizer Inc. (PFE) – Padcev Combination Therapy Receives FDA Priority Review for Expanded Bladder Cancer IndicationFCF Yield - Cổng thông tin điện tử tỉnh Tây Ninh
Pfizer Inc. (PFE)Oncology M&A Precedent Signals Sector Upside Amid Eli Lilly’s Kelonia Acquisition Talks - Cổng thông tin điện tử tỉnh Tây Ninh
Pfizer, Dexcel Take Two Patents Off Table For Bench Trial - Law360
PFE Stock Quote Price and Forecast - CNN
Pfizer (PFE) Executive Strategy Officer Departs Role - GuruFocus
2.42%
6.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):